Creative Planning

Position in GALT — Galectin Therapeutics Inc

CIK 1540235 OVERLAND PARK, KS

Position in GALT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$48,900

+$19,647 QoQ

Shares Held

10,539

+0.5% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#72

of 98 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Creative Planning holds $457,365,908 across 219 Biotechnology names. GALT ranks #198 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	127,672	$63,418,511
2	REGN	Regeneron Pharmaceuticals, Inc.	36,949	$23,039,178
3	EXEL	Exelixis, Inc.	270,292	$14,706,586
4	INCY	Incyte Corp	110,664	$12,544,870
5	CYTK	Cytokinetics Inc	141,939	$12,091,783
6	RVMD	Revolution Medicines, Inc.	64,120	$12,008,393
7	ARGX	Argenx SE	12,744	$11,823,500
8	BMRN	Biomarin Pharmaceutical Inc	153,161	$8,763,872

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$48,900	10,539	+0.5%	Shares	Sole	2026-08-13
2026-03-31	$29,253	10,485	-6.9%	Shares	Sole	2026-05-12
2025-12-31	$46,862	11,265	+8.5%	Shares	Sole	2026-02-17
2025-09-30	$44,032	10,385	-57.1%	Shares	Sole	2025-11-14
2024-03-31	$57,871	24,214	0.0%	Shares	Sole	2024-05-13
2023-12-31	$40,195	24,214	+19.8%	Shares	Sole	2024-02-14
2023-09-30	$38,810	20,214	-4.0%	Shares	Sole	2023-11-16
2023-06-30	$30,309	21,048	0.0%	Shares	Sole	2023-07-21
2023-03-31	$44,200	21,048	0.0%	Shares	Sole	2023-05-15
2022-12-31	$23,784	21,048	0.0%	Shares	Sole	2023-02-10
2022-09-30	$34,308	21,048	0.0%	Shares	Sole	2022-11-03
2022-06-30	$27,572	21,048	0.0%	Shares	Sole	2022-08-15
2022-03-31	$33,887	21,048	+90.5%	Shares	Sole	2022-05-16
2021-12-31	$22,869	11,048	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.